U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H31N5O3S
Molecular Weight 421.557
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SUFOTIDINE

SMILES

CN1N=C(CS(C)(=O)=O)N=C1NCCCOC2=CC=CC(CN3CCCCC3)=C2

InChI

InChIKey=JEYKZWRXDALMNG-UHFFFAOYSA-N
InChI=1S/C20H31N5O3S/c1-24-20(22-19(23-24)16-29(2,26)27)21-10-7-13-28-18-9-6-8-17(14-18)15-25-11-4-3-5-12-25/h6,8-9,14H,3-5,7,10-13,15-16H2,1-2H3,(H,21,22,23)

HIDE SMILES / InChI

Molecular Formula C20H31N5O3S
Molecular Weight 421.557
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Sufotidine is a triazolamine derivative patented by Glaxo Group Ltd. as long-acting histamine H2-blocker useful for the treatment of peptic ulceration and oesophagitis. In phase II clinical treatment with sufotidine decreases median integrated 24-hour intragastric acidity by 95% compared with placebo. Twice daily sufotidine maintained the pH above 3 throughout the 24 h. Unfortunately, no further development report has been published and it seems, that Sufotidine development currently discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Loss of acid suppression during dosing with H2-receptor antagonists.
1990
Sufotidine 600 mg bd virtually eliminates 24 hour intragastric acidity in duodenal ulcer subjects.
1990 Mar
Patents

Sample Use Guides

600 mg bd
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:36:57 UTC 2023
Edited
by admin
on Fri Dec 15 15:36:57 UTC 2023
Record UNII
56B0591Y76
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SUFOTIDINE
INN   USAN  
INN   USAN  
Official Name English
AH-25352X
Code English
sufotidine [INN]
Common Name English
SUFOTIDINE [USAN]
Common Name English
AH 25352X
Code English
Classification Tree Code System Code
NCI_THESAURUS C29702
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
Code System Code Type Description
CAS
80343-63-1
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
PUBCHEM
71763
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
ChEMBL
CHEMBL2105496
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
EVMPD
SUB10673MIG
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
SMS_ID
100000083235
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
NCI_THESAURUS
C73217
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
EPA CompTox
DTXSID50230254
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
INN
5852
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
USAN
Y-17
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
MESH
C062101
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
FDA UNII
56B0591Y76
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
WIKIPEDIA
Sufotidine
Created by admin on Fri Dec 15 15:36:57 UTC 2023 , Edited by admin on Fri Dec 15 15:36:57 UTC 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY